Effective patent life in pharmaceuticals

被引：52

作者：

Grabowski, HG ^{[1
]}

Vernon, JM ^{[1
]}

机构：

[1] Duke Univ, Durham, NC 27708 USA

来源：

INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT | 2000年 / 19卷 / 1-2期

关键词：

effective patent life; pharmaceuticals; innovation; generic competition;

D O I：

10.1504/IJTM.2000.002803

中图分类号：

T [工业技术];

学科分类号：

08 ;

摘要：

Effective patent life is lost in pharmaceuticals because of the lengthy time periods required for clinical trials and regulatory approval. A 1984 US law restores some of this lost patent time, while also facilitating generic competition when patents expire. This paper examines this law and the effects of other policy developments on market exclusivity times in pharmaceuticals. It also performs simulation analyses on how proposed legislative reforms would impact on future new drug introductions.

引用

页码：98 / 120

页数：23

共 20 条

[1]

[Anonymous], 1969, INVENTION GROWTH WEL

[2]

CAVES RE, 1991, BROOKINGS PAP ECO AC, P1

[3] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY [J].